Scholars Central

ArticlePublished 9 Oct 2024

Evaluation of Efficacy and Safety of Roxadustat in Hemodialysis with Renal Anemia

Authors: Qixian Wu, Wen Chen, Xiaoju Fu, Rongyu Lin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective of this study was to explore the effectiveness and safety of roxadustat in the treatment of hemodialysis and renal anemia. Clinical data of 84 individuals having maintenance hemodialysis and renal anemia treated in the dialysis department of our hospital from October 2022 to October 2023 were selected for the analysis and were randomly divided into two groups, control and observation groups each with 42 individuals (n=42). Control group was given intravenous injection of recombinant human erythropoietin while the observation group was given oral roxadustat treatment. The treatment course for both groups was 12 w. After treatment, the clinical effects and various indicators of the two groups of patients were compared, including anemia indicators (red blood cells, hemoglobin and hemocrit value), iron metabolism indicators (serum ferritin, transferrin saturation and transferrin) and the incidence of adverse reactions was analyzed comparatively. After treatment, the drug efficacy of the observation group was higher than that of the control group (p<0.05). Similarly, after treatment anemia indicators and iron metabolism indicators in both groups were higher than before treatment (p<0.05). The adverse reactions of the observation group were less than those of the control group (p<0.05). Roxadustat has a significant effect in treating renal anemia which can effectively improve anemia indicators and iron metabolism indicators. Further, it can also promote blood circulation, ensure the balance of blood and iron metabolism and reduce the incidence of adverse reactions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Qixian Wu”
  • BylineArticles whose byline prints “Wen Chen”
  • BylineArticles whose byline prints “Xiaoju Fu”
  • BylineArticles whose byline prints “Rongyu Lin”